Derek Sharples
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 11
- DNA and Nucleic Acid Chemistry 5
- Phenothiazines and Benzothiazines Synthesis and Activities 4
-
- Synthesis and Biological Evaluation 9
- Synthesis and biological activity 4
- Co-authors
- Jill Barber (3 shared papers)Kenneth T. Douglas (2 shared papers)John A. Parkinson (2 shared papers)John Rosamond (1 shared paper)Jacques Barbe (9 shared papers)Joséph Molnár (3 shared papers)Gabriella Spengler (2 shared papers)Annamária Molnár (2 shared papers)
- Journals
- Journal of Pharmacy and Pharmacology (8 papers)European Journal of Medicinal Chemistry (4 papers)Phytochemistry (3 papers)Chemotherapy (2 papers)FEBS Letters (1 paper)
- Partner nations
- United KingdomFranceHungary
In The Last Decade
Derek Sharples
35 papers receiving 495 citations
Peers
Comparison fields: 5 of 76
- Toxicology 38
- Molecular Medicine 41
- Organic Chemistry 186
- Molecular Biology 291
- Physical and Theoretical Chemistry 26
Countries citing papers authored by Derek Sharples
This map shows the geographic impact of Derek Sharples's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Sharples with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Sharples more than expected).
Fields of papers citing papers by Derek Sharples
This network shows the impact of papers produced by Derek Sharples. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Sharples. The network helps show where Derek Sharples may publish in the future.
Co-authors
The 25 scholars most cited alongside Derek Sharples, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 102 | |
| 2 | 2006 | 69 | |
| 3 | 1990 | 43 | |
| 4 | 2004 | 42 | |
| 5 | 1995 | 22 | |
| 6 | 1976 | 17 | |
| 7 | 1972 | 17 | |
| 8 | 2001 | 16 | |
| 9 | 1969 | 15 | |
| 10 | 1975 | 14 | |
| 11 | 1989 | 14 | |
| 12 | 1972 | 13 | |
| 13 | 2005 | 12 | |
| 14 | 1976 | 12 | |
| 15 | 1984 | 11 | |
| 16 | 1974 | 11 | |
| 17 | 1981 | 9 | |
| 18 | 1990 | 8 | |
| 19 | 1982 | 8 | |
| 20 | The inhibition of SOS-responses and MDR by phenothiazine-metal complexes. | 1998 | 7 |
About Derek Sharples
Derek Sharples is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Toxicology and Pharmacology, having authored 35 papers that have together received 514 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Synthesis and Biological Evaluation (9 papers), Bioactive Compounds and Antitumor Agents (5 papers), DNA and Nucleic Acid Chemistry (5 papers), Synthesis and biological activity (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cassava research and cyanide (3 papers). The work is most often cited by research in Toxicology (38 citations), Molecular Medicine (41 citations), Organic Chemistry (186 citations), Molecular Biology (291 citations) and Physical and Theoretical Chemistry (26 citations). Derek Sharples has collaborated with scholars based in United Kingdom, France and Hungary. Frequent co-authors include Jill Barber, Kenneth T. Douglas, John A. Parkinson, John Rosamond, Jacques Barbe, Joséph Molnár, Gabriella Spengler, Annamária Molnár, Jean‐Pierre Galy and Zsuzsanna Schelz. Their work appears in journals such as Journal of Pharmacy and Pharmacology, European Journal of Medicinal Chemistry, Phytochemistry, Chemotherapy and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.